J Korean Foot Ankle Soc.  2019 Mar;23(1):18-23. 10.14193/jkfas.2019.23.1.18.

Statistical Analysis of the Risk Factors for Single Toe Amputation Patients in Wound Healing

• Chung HJ
• Bae SY
• Shin WJ
• Lee JH

• KMID: 2440580
• DOI: http://doi.org/10.14193/jkfas.2019.23.1.18

Abstract

PURPOSE
This study compared and analyzed the risk factors that affect a wound healing group and healing failure group.
MATERIALS AND METHODS
From 2010 to 2018, 39 patients who had suffered a single toe amputation were evaluated retrospectively. The patients were divided into two groups (wound healing group and healing failure group - within at least 3 months following the amputation). Regarding the possible risk factors, age, gender, Wagner and Brodsky classifications, duration of diabetes mellitus, whether the patient had peripheral arterial occlusive disease (PAOD) or cardiovascular disease, body mass index, HbA1c, total cholesterol, estimated glomerular filtration rate (eGFR), blood urea nitrogen (BUN), smoking, and alcohol were investigated.
RESULTS
The mean duration of diabetes mellitus was 140 months in the healing group and 227 months in the healing failure group, and the duration of diabetes was significantly longer in the failure group (p=0.009). A significant difference in eGFR was observed between the two groups (59.17 mL/min/1.73 m2 in the healing group and 31.1 mL/min/1.73 m2 in the failure group) (p=0.022). Sixteen patients with PAOD were found, all 10 patients in the healing failure group were PAOD patients.
CONCLUSION
To reduce the additional complications in single toe amputation patients, the underlying disease and appropriate treatment are the most important factors. In addition, a more proximal level of amputation also should be considered in cases of patients with PAOD, high BUN and low eGFR, and patients with long-term diabetes.

Keyword

Toe amputation; Diabetes mellitus; Arterial occlusive disease

MeSH Terms

Amputation*
Arterial Occlusive Diseases
Blood Urea Nitrogen
Body Mass Index
Cardiovascular Diseases
Cholesterol
Classification
Diabetes Mellitus
Glomerular Filtration Rate
Humans
Retrospective Studies
Risk Factors*
Smoke
Smoking
Toes*
Wound Healing*
Wounds and Injuries*
Cholesterol
Smoke

Reference

1.Bae JI., Won JH., Han SH., Lim SH., Hong YS., Kim JY, et al. Endo-vascular revascularization for patients with critical limb ischemia: impact on wound healing and long term clinical results in 189 limbs. Korean J Radiol. 2013. 14:430–8.

2.Myerson MS., Bowker JH., Brodsky JW., Trevino S. Symposium: partial foot amputations. Contemp Orthop. 1994. 29:139–42. 146-57.

3.Canaud L., Alric P., Berthet JP., Marty-Ané C., Mercier G., Branchereau P. Infrainguinal cutting balloon angioplasty in de novo arterial lesions. J Vasc Surg. 2008. 48:1182–8.

4.Sharp CS., Bessman AN., Wagner FW Jr., Garland D. Microbiology of deep tissue in diabetic gangrene. Diabetes Care. 1978. 1:289–92.

5.Brodsky JW. Evaluation of the diabetic foot. Instr Course Lect. 1999. 48:289–303.

6.Roon AJ., Moore WS., Goldstone J. Below-knee amputation: a modern approach. Am J Surg. 1977. 134:153–8.

7.Dickhaut SC., DeLee JC., Page CP. Nutritional status: importance in predicting wound-healing after amputation. J Bone Joint Surg neuropathy. Baseline analysis of neuropathy in feasibility phase of Diabetes Control and Complications Trial (DCCT). Diabetes. 1988. 37:476–81. Am. 1984;66: 71-5.

8.Wagner FW Jr. Management of the diabetic neurotrophic foot part II. A classification and treatment program for diabetic, neuropathic, and dysvascular foot problems. The American Academy of Orthopaedic Surgeons. editor.Instructional course lectures. St. Louis: C.V. Mosby;1979. p. 143–65.

15.Lee WC., Park HS., Kim HC., Kim CS., Choi DS., Rha JD. Influence of neuropathy and ischemia in the development and treatment of the diabetic foot. J Korean Orthop Assoc. 1999. 34:749–53.

16.Mayfield JA., Reiber GE., Nelson RG., Greene T. A foot risk classification system to predict diabetic amputation in Pima Indians. Diabetes Care. 1996. 19:704–9.

17.National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002. 39(2 Suppl 1):S1–266.

10.Singh N., Armstrong DG., Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA. 2005. 293:217–28.

11.Swaminathan A., Vemulapalli S., Patel MR., Jones WS. Lower extremity amputation in peripheral artery disease: improving patient outcomes. Vasc Health Risk Manag. 2014. 10:417–24.

18.Kwon SH., Han DC. Diagnosis and screening of chronic kidney disease. Korean J Med. 2009. 76:515–20.

19.Miyajima S., Shirai A., Yamamoto S., Okada N., Matsushita T. Risk factors for major limb amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract. 2006. 71:272–9.

12.Adler AI., Boyko EJ., Ahroni JH., Smith DG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care. 1999. 22:1029–35.

20.Armstrong DG., Frykberg RG. Classifying diabetic foot surgery: toward a rational definition. Diabet Med. 2003. 20:329–31.

13.Maser RE., Steenkiste AR., Dorman JS., Nielsen VK., Bass EB., Man-joo Q, et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes. 1989. 38:1456–61.

21.Nehler MR., Whitehill TA., Bowers SP., Jones DN., Hiatt WR., Rutherford RB, et al. Intermediate-term outcome of primary digit amputations in patients with diabetes mellitus who have forefoot sepsis requiring hospitalization and presumed adequate circulatory status. J Vasc Surg. 1999. 30:509–17.

14.The DCCT Research Group. Factors in development of diabetic.